Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics
Fierce Pharma
Mon, 06/12/17 - 09:42 am
Sanofi
Regeneron
Praluent
diabetes
LDL cholesterol
Why Regeneron Is Quickly Becoming My Top Biotech Stock Pick
Motley Fool
Mon, 06/5/17 - 10:09 am
Regeneron
Sanofi, Regeneron set Kevzara up for tough rheumatoid arthritis turf battle with $39K list price
Fierce Pharma
Wed, 05/24/17 - 10:35 am
Sanofi
Regeneron
Kevzara
rheumatoid arthritis
Celgene, Regeneron and Vertex execs, NIH chief head to White House as threat of Trump funding cuts looms
Fierce Biotech
Mon, 05/8/17 - 10:04 pm
biotech
Celgene
Regeneron
Vertex Pharmaceuticals
NIH
Donald Trump
Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts
Fierce Pharma
Mon, 05/8/17 - 11:38 am
Sanofi
Regeneron
drug launches
Dupixent
eczema
Regeneron posts mixed Q1 results, Eylea growth slows
Drug Delivery Business News
Sun, 05/7/17 - 10:13 am
Regeneron
earnings
Eylea
5 Big Drugmakers With Important Catalysts in May
Motley Fool
Sun, 04/30/17 - 01:00 pm
FDA
Merck
Keytruda
Isentress
Novartis
PKC412
Novo Nordisk
nonacog beta pegol
Sanofi
Regeneron
Kevzara
Will Regeneron’s Revenue Surpass Analysts’ Estimates in 1Q17?
Market Realist
Wed, 04/26/17 - 09:40 pm
Regeneron
earnings
Regeneron’s CEO, CSO saw their compensation slashed in ’16 — but it’s still a jaw-dropping sum
Endpoints
Tue, 04/25/17 - 11:50 pm
Regeneron
Pharma CEOs
executive pay
Leonard Schleifer
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection
Yahoo
Tue, 04/25/17 - 11:04 am
Sanofi
Regeneron
FDA
Praluent
EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
Yahoo/Reuters
Sat, 04/22/17 - 01:14 pm
Europe
EMA
Sanofi
Regeneron
rheumatoid arthritis
Kevzara
Sarilumab
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain
Motley Fool
Mon, 04/17/17 - 12:09 pm
Eli Lilly
Inctye
AbbVie
Regeneron
rheumatoid arthritis
FDA
baricitinib
Humira
When do pharmas disclose launch prices up front? When they’re pricing at a discount
Fierce Pharma
Fri, 04/14/17 - 10:03 am
drug discounts
drug pricing
Roche
Neurocrine
Sanofi
Regeneron
Tesaro
Novartis
3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Regeneron
Praluent
Amgen
biosimilars
Amjevita
Humira
ABP-215
Avastin
ABP-980
Herceptin
Celgene
ozanimod
The stellar antibody shop at Regeneron wins a ‘breakthrough’ tag for its next big PhIII drug
Endpoints
Fri, 04/7/17 - 09:48 am
Regeneron
breakthrough therapies
evinacumab
LDL cholesterol
How a $37,000-a-year medicine sets a good model for drug pricing
Stat
Tue, 04/4/17 - 12:17 am
drug pricing
psoriasis
Dupixent
Regeneron
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Tue, 04/4/17 - 12:13 am
Eli Lilly
Pfizer
Sanofi
AbbVie
Regeneron
patents
PCSK9 inhibitors
Repatha
Sarepta chief hands over CMO role to former Regeneron exec
Bizjournals.com
Tue, 04/4/17 - 12:09 am
Sarepta Therapeutics
Regeneron
CMOs
Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster
Motley Fool
Thu, 03/30/17 - 09:39 am
Regeneron
eczema
Sanofi
Dupixent
Can a $37,000 price be right? For Dupixent, analysts (and one payer) say yes
Fierce Pharma
Wed, 03/29/17 - 11:58 am
drug pricing
Dupixent
Sanofi
Regeneron
eczema
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »